Encompassing the full spectrum of project management’s role and responsibility encountered in the pharmaceutical industry, Pharmaceutical Project Management outlines the key objectives, risks, and challenges of each stage of the pharmaceutical lifecycle, from discovery and preclinical phases through clinical development, manufacturing, registration, and launch.
New updated material includes:
It covers primary project management objectives, functions, and descriptions of the nature and execution of work activities in a clear and reader-friendly format to illustrate key characteristics and objectives, assist managers in projecting the risks and challenges of each development option, and supply concise recommendations for successful project planning.
Die Inhaltsangabe kann sich auf eine andere Ausgabe dieses Titels beziehen.
Tony Kenedy is Vice President of Development at Trigen, Ltd in London, U.K. Dr. Kennedy, a Medical Research Council Postdoctoral Research Fellow at The School of Pharmacy, London University, U.K., was awarded his Ph.D. by London University, U.K. and was previously the Global Head of Project Management at Roche, Switzerland. He was the editor of the first edition of Pharmaceutical Project Management which was published by Marcel Dekker in 1998, and his career has been devoted to the discovery and development of novel drugs while working in large pharmaceutical and small biotech companies. Dr. Kennedy has directed global drug development teams in several therapeutic areas including cardiovascular, gastrointestinal, infectious disease, rheumatology and oncology, and led the Roche-Gilead joint development team that took the flu antiviral Tamiflu to registration three years after the discovery of the molecule.
Encompassing the full spectrum of project management's role and responsibility encountered in the pharmaceutical industry, Pharmaceutical Project Management outlines the key objectives, risks, and challenges of each stage of the pharmaceutical lifecycle, from discovery and preclinical phases through clinical development, manufacturing, registration, and launch.
„Über diesen Titel“ kann sich auf eine andere Ausgabe dieses Titels beziehen.
Anbieter: Romtrade Corp., STERLING HEIGHTS, MI, USA
Zustand: New. Brand New. Soft Cover International Edition. Different ISBN and Cover Image. Priced lower than the standard editions which is usually intended to make them more affordable for students abroad. The core content of the book is generally the same as the standard edition. The country selling restrictions may be printed on the book but is no problem for the self-use. This Item maybe shipped from US or any other country as we have multiple locations worldwide. Artikel-Nr. ABBB-65340
Anbieter: PsychoBabel & Skoob Books, Didcot, Vereinigtes Königreich
Hardcover. Zustand: Very Good. Zustand des Schutzumschlags: No Dust Jacket. Second Edition. Drugs and the Pharmaceutical Sciences series, Volume 182. Very good, almost as-new condition; minor shelf wear to cover only. Contents clean, bright, sound throughout. Used. Artikel-Nr. 202092
Anzahl: 1 verfügbar
Anbieter: ThriftBooks-Atlanta, AUSTELL, GA, USA
Hardcover. Zustand: Good. No Jacket. Missing dust jacket; Pages can have notes/highlighting. Spine may show signs of wear. ~ ThriftBooks: Read More, Spend Less. Artikel-Nr. G0849340241I3N01
Anzahl: 1 verfügbar
Anbieter: Revaluation Books, Exeter, Vereinigtes Königreich
Hardcover. Zustand: Brand New. 2nd edition. 350 pages. 9.50x6.00x0.75 inches. In Stock. Artikel-Nr. x-0849340241
Anzahl: 2 verfügbar